SGMO
Sangamo Therapeutics, IncCompany with tickers: SGMO
CIK
1001233
CUSIP
800677106
Shares Outstanding
414,288,847
13F Activity (30d)
65 filings
63 filers
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2023-04-26 | — | |
| 8-K | 2023-03-17 | 2023-03-13 | |
| 8-K | 2023-03-14 | 2023-03-13 | |
| 8-K | 2023-03-10 | — | |
| 8-K | 2023-03-07 | — | |
| 8-K | 2023-03-02 | — | |
| 10-K | 2023-02-23 | 2022-12-31 | |
| 8-K | 2023-02-22 | — | |
| 8-K | 2022-12-23 | — | |
| 8-K | 2022-12-19 | 2022-12-15 | |
| 8-K | 2022-12-12 | 2022-12-10 | |
| 10-Q | 2022-11-03 | 2022-09-30 | |
| 8-K | 2022-11-03 | — | |
| 8-K | 2022-10-12 | — | |
| 8-K | 2022-09-22 | — | |
| 8-K | 2022-08-30 | — | |
| 8-K | 2022-08-09 | 2022-08-08 | |
| 8-K | 2022-08-04 | — | |
| 10-Q | 2022-08-04 | 2022-06-30 | |
| 8-K | 2022-05-25 | 2022-05-24 | |
| 8-K | 2022-05-05 | — | |
| 10-Q | 2022-05-05 | 2022-03-31 | |
| 8-K | 2022-04-01 | 2022-03-28 | |
| 8-K | 2022-03-28 | 2022-03-22 | |
| 10-K | 2022-02-24 | 2021-12-31 | |
| 8-K | 2022-02-24 | — | |
| 8-K | 2022-02-09 | 2022-02-07 | |
| 8-K | 2022-01-06 | 2021-12-30 | |
| 8-K | 2021-12-13 | 2021-12-12 | |
| 8-K | 2021-11-22 | 2021-11-17 | |
| 10-Q | 2021-11-04 | 2021-09-30 | |
| 8-K | 2021-11-04 | — | |
| 8-K | 2021-10-22 | 2021-10-18 | |
| 10-Q | 2021-08-05 | 2021-06-30 | |
| 8-K | 2021-08-05 | — | |
| 8-K | 2021-07-01 | 2021-06-28 | |
| 8-K | 2021-05-28 | 2021-05-25 | |
| 8-K/A | 2021-05-27 | 2021-03-11 | |
| 8-K | 2021-05-04 | — | |
| 10-Q | 2021-05-04 | 2021-03-31 | |
| 8-K | 2021-03-17 | 2021-03-11 | |
| 10-K | 2021-02-24 | 2020-12-31 | |
| 8-K | 2021-02-24 | — | |
| 8-K | 2021-01-28 | 2021-01-22 | |
| 8-K | 2021-01-14 | — | |
| 8-K | 2021-01-06 | 2020-12-31 | |
| 8-K | 2020-12-15 | 2020-12-14 | |
| 8-K | 2020-12-07 | — | |
| 10-Q | 2020-11-04 | 2020-09-30 | |
| 8-K | 2020-11-04 | — |
Showing 51–100 of 114 filings